Juno Therapeutics pays $59M for Stage Cell Therapeutics, continues to burn cash in search of cancer treatment Juno Therapeutics has paid $59 million to acquire Stage Cell Therapeutics, a privately held biotech company based in Germany. Stage… Read More
